These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Minocycline in acne vulgaris: benefits and risks. Ochsendorf F Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295 [TBL] [Abstract][Full Text] [Related]
28. Doxycycline-Associated Hyperpigmentation: A Case Report and Literature Review. Afrin A; Cohen PR Cureus; 2022 Apr; 14(4):e23754. PubMed ID: 35509754 [TBL] [Abstract][Full Text] [Related]
29. Black Bone Disease of the Foot: A Two-Year Follow-Up Case Study. Cornejo A; Kerbleski GJ J Foot Ankle Surg; 2018; 57(6):1259-1262. PubMed ID: 30001940 [TBL] [Abstract][Full Text] [Related]
30. Blue-grey hyperpigmentation in acne after vandetanib therapy and doxycycline use: A case report. Perlmutter JW; Cogan RC; Wiseman MC SAGE Open Med Case Rep; 2022; 10():2050313X221086316. PubMed ID: 35341100 [TBL] [Abstract][Full Text] [Related]
32. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Margolis DJ; Fanelli M; Hoffstad O; Lewis JD Am J Gastroenterol; 2010 Dec; 105(12):2610-6. PubMed ID: 20700115 [TBL] [Abstract][Full Text] [Related]
33. Minocycline-induced hyperpigmentation in patients with pemphigus and pemphigoid. Ozog DM; Gogstetter DS; Scott G; Gaspari AA Arch Dermatol; 2000 Sep; 136(9):1133-8. PubMed ID: 10987869 [TBL] [Abstract][Full Text] [Related]